Spermidine 60 Caps

 An early 3-month pilot trial (n=30) in older adults with subjective cognitive decline reported a positive impact on memory performance with spermidine supplementation.

Yes, most notable the Smart Age study produced a positive finding on a biomarker called sICAM-1 (soluble intercellular adhesion molecule-1), a marker of vascular inflammation associated with cognitive decline and cardiovascular risk. The spermidine group showed a meaningful reduction in sICAM-1 compared to the placebo group over 12 months, a statistically significant difference. This is a real, specific, quantified result , not a vague "trend toward improvement." It supports spermidine's proposed mechanism (autophagy, cellular maintenance) showing up in an actual inflammatory biomarker.

Yes, across both the pilot and the 12-month SmartAge trial, adverse events were balanced between the spermidine and placebo groups, with no signal of meaningful safety concerns.

Spermidine is a naturally occurring polyamine studied for its role in autophagy — the cellular process of clearing out damaged components. This mechanism is well-documented in cell and animal research. What's less settled is how reliably that translates into a measurable human outcome like memory or longevity, which is exactly what trials like SmartAge are trying to pin down.

Yes, this is one of the more consistently supported claims for beta-sitosterol. A meta-analysis of 14 randomized controlled trials found that plant sterols and stanols (including beta-sitosterol) reduced cholesterol levels, and human research has used doses between 500 mg and 10 grams per day to achieve this effect. This is a well-replicated finding, not a single-study result.

Yes, the strongest clinical evidence outside of cholesterol is for prostate/urinary symptoms. A randomized, double-blind, placebo-controlled trial of 200 patients with benign prostatic hyperplasia (BPH) found that beta-sitosterol significantly improved urinary symptom scores and peak urine flow compared to placebo over 6 months, though it didn't reduce prostate volume. This is a well-controlled trial with a clear result, though it's specific to BPH symptom relief rather than general wellness.